Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02930408
Other study ID # STEINECHO
Secondary ID
Status Terminated
Phase N/A
First received October 10, 2016
Last updated October 11, 2016
Start date January 2014

Study information

Verified date August 2016
Source Poitiers University Hospital
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

Steinert's disease is an orphan disease. The prognosis of patients with this disease is conditioned by cardiac involvement. Search an early stage alterations in contractile function in subjects suffering from dystrophy would detect patients at risk of sudden death. The first stage of work is to validate the tools to detect early stage of infringement systolic function in a population of patients with myotonic dystrophy.


Recruitment information / eligibility

Status Terminated
Enrollment 70
Est. completion date
Est. primary completion date July 2015
Accepts healthy volunteers
Gender Both
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria:

- patients suffering from muscular dystrophy type 1 followed CHU Poitiers.

- age = 18 years

Exclusion Criteria:

- duration QRS> 120 ms ECG permanent ventricular stimulation

- trouble segmental kinetic obvious to echocardiography in visual analysis

Study Design

N/A


Related Conditions & MeSH terms


Intervention

Procedure:
electrocardiogram

Echocardiography


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Poitiers University Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Ventricular Ejection Fraction Left 3D Immediately
Primary Global longitudinal systolic Strain Immediately
Primary Strain of the dispersion index Immediately
See also
  Status Clinical Trial Phase
Recruiting NCT00082108 - Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
Not yet recruiting NCT05532813 - Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease) Phase 3
Recruiting NCT02398786 - Myotonic Dystrophy Family Registry